According to ancient records, loquat leaf has been used as both a food and medicine in China for thousands of years. Sesquiterpene glycosides from loquat leaf have achieved remarkable effects on hyperglycemia. However, their specific activities and underlying mechanisms on type 2 diabetes mellitus (T2DM) are not fully understood. In the present study, we found that SG1, a unique sesquiterpene glycoside isolated from loquat leaf, had the capability to prevent insulin resistance and inflammation. In db/db mice, SG1 administration (25 and 50 mg kg−1 day−1) inhibited hyperglycemia and the release of inflammatory cytokines. To further explore the possible role of gut microbiota in SG1 for treating T2DM, we applied 16S rRNA pyrosequencing based on the V3–V4 region to analyze the fecal samples of different groups. Alpha diversity analysis showed that SG1 administration could obviously increase diversity and richness in db/db mice. At the phylum level, due to SG1 treatment, the relative abundance of Firmicutes and Actinobacteria was lowered while that of Bacteroidetes was raised. Additionally, 7 key genera in the db/db mice with SG1 supplementation were enriched: Lactobacillus, Lachnospiraceae_NK4A136_group, and Ruminococcus, Bacteroides, Prevotellaceae_UCG-001, Alistipes, and Roseburia. These findings proved that SG1 could prevent T2DM by relieving insulin resistance and inflammation and by remodeling the gut microbiota in db/db mice.
1 January 2021 in Oxidative Medicine and Cellular Longevity
Loquat (Eriobotrya japonica Lindl.), a subtropical fruit tree native to Asia, is not only known to be nutritive but also beneficial for the treatment of diabetes in the south of China. To expand its development, this study was undertaken concerning the potential therapeutic role of total sesquiterpene glycosides (TSGs) from loquat leaves in insulin resistance (IR), the major causative factor of type 2 diabetes mellitus (T2DM). Male C57BL/6 mice were fed on high‐fat diet (HFD) to induce IR and then were given TSG by oral administration at 25 and 100 mg/kg/day, respectively. TSG notably improved metabolic parameters including body weight, serum glucose, and insulin levels and prevented hepatic injury. Moreover, inflammatory response and oxidative stress were found to be remarkably alleviated in IR mice with TSG supplement. Further research in liver of IR mice demonstrated that TSG repaired the signalings of insulin receptor substrate‐1 (IRS‐1)/glucose transporter member 4 (GLUT4) and AMP‐activated protein kinase (AMPK), which improved glucose and lipid metabolism and prevented lipid accumulation in liver. It was also observed that TSG suppressed the expression of transient receptor potential vanilloid 1 (TRPV1), whereas the signaling pathway of sirtuin‐6 (SIRT6)/nuclear factor erythroid 2‐related factor 2 (Nrf2) was significantly promoted. Based on the results, the current study demonstrated that TSG from loquat leaves potentially ameliorated IR in vivo by enhancing IRS‐1/GLUT4 signaling and AMPK activation and modulating TRPV1 and SIRT6/Nrf2 signaling pathways.
5 October 2022 in Journal of Agricultural and Food Chemistry